# US 6,727,066 B2 · Genes expressed in treated human C3A liver cell cultures

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 6,727,066 B2
- Document ID: US6727066B2
- Status: Granted
- Kind: B2
- Application number: 09/919,039
- Filed: 2001-07-30
- Published: 2003-06-12
- Granted: 2004-04-27
- Earliest claimed: 2000-07-28
- Assignees: Incyte Corporation
- Inventors: Matthew R. Kaser
- Web page: https://patentgrep.com/patent/US6727066B2

## CPC

- G01N 33/6893: {related to diseases not provided for elsewhere}
- C12Q 1/6883: for diseases caused by alterations of genetic material
- C12Q 2600/136: Screening for pharmacological compounds
- C12Q 2600/156: Polymorphic or mutational markers
- C12Q 2600/158: Expression markers
- G01N 2800/52: Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
- Y02A 90/10: Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- Y02A: TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE

## Abstract

The present invention relates to a composition comprising a plurality of cDNAs which are differentially expressed in treated human C3A liver cell cultures and which may be used entirely or in part to diagnose, to stage, to treat, or to monitor the progression or treatment of liver disorders such as hyperlipidemia.

## Claims

### Claim 1

A composition comprising a plurality of cDNAs, said plurality of cDNAs comprising a sequence selected from SEQ ID NOs: 32, 186, 308, 323, or their complements.

### Claim 2 (depends on 1)

The composition of claim 1, wherein said plurality of cDNAs comprises SEQ ID NO:32.

### Claim 3 (depends on 1)

The composition of claim 1, wherein said plurality of cDNAs comprises SEQ ID NO:186.

### Claim 4 (depends on 1)

The composition of claim 1, wherein the cDNAs are immobilized on a substrate.

### Claim 5 (depends on 4)

A high throughput method for detecting differential expression of one or more cDNAs in a sample containing nucleic acids, the method comprising:
(a) hybridizing the substrate of the composition of claim 4 with nucleic acids of the sample, thereby forming one or more hybridization complexes;
(b) detecting the hybridization complexes; and
(c) comparing the hybridization complexes with those of a standard, wherein differences between the standard and sample hybridization complexes indicate differential expression of cDNAs in the sample.

### Claim 6 (depends on 5)

The method of claim 5, wherein the nucleic acids of the sample are amplified prior to hybridization.

### Claim 7 (depends on 1)

A high throughput method of screening a plurality of molecules or compounds to identify a ligand which specifically binds a cDNA, the method comprising:
(a) combining the composition of claim 1 with the plurality of molecules or compounds under conditions to allow specific binding; and
(b) detecting specific binding between each cDNA and at least one molecule or compound, thereby identifying a ligand that specifically binds to each cDNA.

### Claim 8 (depends on 7)

The method of claim 7 wherein the plurality of molecules or compounds are selected from DNA molecules, RNA molecules, peptide nucleic acid molecules, mimetics, peptides, transcription factors, repressors and regulatory proteins.

### Claim 9

An isolated cDNA selected from SEQ ID NOs:32, 186, 308, and 323.

### Claim 10 (depends on 9)

A vector containing the cDNA of claim 9.

### Claim 11 (depends on 10)

A host cell containing the vector of claim 10.

### Claim 12 (depends on 11)

A method for producing a protein, the method comprising the steps of:
(a) culturing the host cell of claim 11 under conditions for expression of protein; and
(b) recovering the protein from the host cell culture.

### Claim 13 (depends on 5)

The method of claim 5, wherein the sample is from liver, and differential expression is diagnostic of hyperlipidemia, hypertension, type II diabetes, or a liver tumor.
